Unknown

Dataset Information

0

Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy.


ABSTRACT: Vascular endothelial growth factors (VEGFs) bind to membrane receptors on a wide variety of cells to regulate diverse biological responses. The VEGF-A family member promotes vasculogenesis and angiogenesis, processes which are essential for vascular development and physiology. As angiogenesis can be subverted in many disease states, including tumour development and progression, there is much interest in understanding the mechanistic basis for how VEGF-A regulates cell and tissue function. VEGF-A binds with high affinity to two VEGF receptor tyrosine kinases (VEGFR1, VEGFR2) and with lower affinity to co-receptors called neuropilin-1 and neuropilin-2 (NRP1, NRP2). Here, we use a structural viewpoint to summarise our current knowledge of VEGF-VEGFR activation and signal transduction. As targeting VEGF-VEGFR activation holds much therapeutic promise, we examine the structural basis for anti-angiogenic therapy using small-molecule compounds such as tyrosine kinase inhibitors that block VEGFR activation and downstream signalling. This review provides a rational basis towards reconciling VEGF and VEGFR structure and function in developing new therapeutics for a diverse range of ailments.

SUBMITTER: Shaik F 

PROVIDER: S-EPMC7765180 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural Basis for Vascular Endothelial Growth Factor Receptor Activation and Implications for Disease Therapy.

Shaik Faheem F   Cuthbert Gary A GA   Homer-Vanniasinkam Shervanthi S   Muench Stephen P SP   Ponnambalam Sreenivasan S   Harrison Michael A MA  

Biomolecules 20201215 12


Vascular endothelial growth factors (VEGFs) bind to membrane receptors on a wide variety of cells to regulate diverse biological responses. The VEGF-A family member promotes vasculogenesis and angiogenesis, processes which are essential for vascular development and physiology. As angiogenesis can be subverted in many disease states, including tumour development and progression, there is much interest in understanding the mechanistic basis for how VEGF-A regulates cell and tissue function. VEGF-A  ...[more]

Similar Datasets

| S-EPMC2723825 | biostudies-literature
| S-EPMC3322888 | biostudies-literature
| S-EPMC34643 | biostudies-literature
| S-EPMC5560693 | biostudies-literature
| S-EPMC6568257 | biostudies-literature
| S-EPMC3442373 | biostudies-literature
| S-EPMC6783537 | biostudies-literature
| S-EPMC2267239 | biostudies-literature
| S-EPMC2970665 | biostudies-literature
| S-EPMC4517055 | biostudies-literature